Skip to main content

Table 1 Demographics of patients who completed the ACT versus did not complete the ACT

From: Asthma self-assessment in a Medicaid population

N = 95
n (%)
Completed ACT
(n = 28)
Did not complete ACT (n = 67) Total p-value
Employed outside home?     0.11
   Yes 8 (29%) 32 (48%) 40 (42%)  
   No 20 (71%) 35 (52%) 55 (58%)  
Race/ethnicity     
   White 15 (54%) 34 (51%) 49 (52%) 0.18
   Black/African-American 8 (28%) 23 (34%) 31 (33%)  
   Latino 2 (7%) 9 (13.5%) 11 (11%)  
   Other 3 (11%) 1 (1.5%) 4 (4%)  
Highest grade completed     
   Some high school or less 6 (21%) 12 (18%) 18 (19%) 0.21
   High school graduate/some college 20 (72%) 40 (60%) 60 (60%)  
   Post graduate/college 2 (7%) 15 (22%) 17 (22%)  
Household income     
   $15,000 or less 11 (44%) 24 (37%) 35 (38%) 0.46
   $15,000–$30,000 9 (36%) 20 (30%) 29 (32%)  
   More than $30,000 5 (20%) 22 (33%) 27 (30%)  
Using this type of medication in the past 12 months     
   Beta agonists 26 (38%) 62 (34%) 88 (35%) 0.60
   Inhaled corticosteroid 14 (20%) 27 (15%) 41 (16%)  
   Long acting beta agonists (LABA) 2 (3%) 4 (2%) 6 (2%)  
   ICS/LABA 12 (17%) 38 (21%) 50 (20%)  
   Oral corticosteroid 2 (3%) 16 (9%) 18 (7%)  
   Mast cell stabilizers 9 (13%) 22 (12%) 31 (12%)  
   Ipratroprium 4 (6%) 10 (5%) 14 (6%)  
   Theophylline 0 4 (2%) 4 (2%)